comparemela.com

Latest Breaking News On - Business review committee - Page 1 : comparemela.com

PharmaCyte Biotech Makes $7 Million Strategic Investment in MyMD, A Biopharmaceutical Company Focused on Inflammatory Disease

Second external investment in life sciences solidifies previously announced strategy to utilize significant cash position to create additional stockholder value .

Chris chapmanMichael abecassisCompany board of directorsBusiness review committeeMymd pharmaceuticals incDrug administrationPharmacyte biotech incPharmacyte biotechCell ina boxPrivate securities litigation reform act

Cardinal Health Reports Third Quarter Fiscal Year 2024 Results and Raises Fiscal Year 2024 Non-GAAP EPS Guidance

Revenue increased 9% to $54.9 billionGAAP1 operating earnings were $367 million; GAAP diluted EPS was $1.05Non-GAAP operating earnings increased 10% to $666 million; non-GAAP diluted EPS increased.

United statesErich timmermanJason hollarDebbie weitzmanRobert bob azelbyMichelle greeneMatt simsElliott internationalDepartment of justiceAttributable to cardinal health incCardinal healthPrnewswire cardinal healthCardinal health us medical productsCardinal health formSpecialty networksSpecialty solutions

Cardinal Health Reports Second Quarter Fiscal 2024 Results and Raises Fiscal 2024 Outlook

Revenue increased 12% to $57.4 billionGAAP1 operating earnings were $482 million; GAAP diluted EPS was $1.43Non-GAAP operating earnings increased 20% to $562 million; non-GAAP diluted EPS increased.

United statesJason hollarErich timmermanMatt simsAttributable to cardinal health incCardinal health formPrnewswire cardinal healthElliott internationalSpecialty solutionsCardinal health incSpecialty networksElliott associatesCardinal health brandHome solutionsPrecision health solutionsHealth solutions

Christopher Kubasik: L3Harris to Put Off M&A Program for Foreseeable Future

Looking for the latest GovCon News? Check out our story: Christopher Kubasik: L3Harris to Put Off M&A Program for Foreseeable Future. Click to read more!

United statesAerojet rocketdyneChristopher kubasikBusiness review committeeGovcon wireDaily updatesNews briefings

L3Harris Technologies (LHX) Details Financial Objectives and Value Creation Strategy

L3Harris Technologies (LHX) Details Financial Objectives and Value Creation Strategy
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Christophere kubasikBusiness review committeeTrusted disruptorInvestor relations

vimarsana © 2020. All Rights Reserved.